Description  | 1
Day Price Change % | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | -0.75 | 2138.8B | 22.36 | 13.70 | 2.36 | 0.71 | 10.09 | 11.16 | 288.90 |
| Industry: Drug Manufacturers - Major (More Info) | -0.93 | 1067.4B | 16.20 | 19.60 | 3.75 | 0.47 | 9.72 | 16.80 | 152.20 |
| Companies | |||||||||
| Wyeth (WYE) | 1.26 | 63.4B | 14.20 | 26.56 | 2.40 | 0.60 | 3.29 | 20.96 | -258.22 |
| WuXi PharmaTech (Cayman) Inc. (WX) | -0.75 | 1.2B | 33.13 | 23.72 | NA | 0.18 | 3.94 | 24.29 | NA |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.3M | NA | NA | NA | NA | NA | NA | NA |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -4.35 | 41.5M | NA | -84.94 | NA | NA | 1.00 | NA | -6.57 |
| Schering-Plough Corp. (SGP) | 0.76 | 32.3B | NA | -18.16 | 1.30 | 0.89 | 3.79 | 6.25 | 69.89 |
| Sanofi-Aventis (SNY) | -0.77 | 92.5B | 11.96 | NA | 3.20 | 0.13 | 1.33 | 25.80 | NA |
| Rigel Pharmaceuticals, Inc. (RIGL) | -2.76 | 797.5M | NA | -64.36 | NA | 0.01 | 4.21 | NA | -34.35 |
| Quick-Med Technologies Inc. (QMDT.OB) | -7.89 | 10.8M | NA | NA | NA | NA | NA | -146.70 | -39.65 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 8.43 | 45.5M | NA | -67.71 | NA | NA | 3.38 | NA | -24.83 |
| Pfizer Inc. (PFE) | -2.03 | 117.6B | 15.84 | 10.92 | 7.20 | 0.25 | 1.75 | 23.50 | -183.07 |
| Oscient Pharmaceuticals Corp. (OSCI) | -6.00 | 19.9M | NA | NA | NA | NA | NA | -116.61 | -5.42 |
| Novartis AG (NVS) | -0.99 | 127.2B | 10.68 | 14.99 | 2.60 | 0.13 | 2.58 | 22.68 | 566.60 |
| Neurologix Inc. (NRGX.OB) | -3.13 | 17.1M | NA | -51.09 | NA | NA | 0.93 | NA | -9.98 |
| Minrad International Inc. (BUF) | -0.50 | 97.3M | NA | -74.74 | NA | 0.70 | 5.01 | -26.85 | -8.90 |
| Merck & Co. Inc. (MRK) | -4.81 | 78.6B | 16.46 | 25.65 | 4.00 | 0.23 | 4.03 | 56.73 | -74.32 |
| Keryx Biopharmaceuticals Inc. (KERX) | -6.00 | 20.5M | NA | -177.27 | NA | NA | 1.90 | NA | -0.87 |
| Johnson & Johnson (JNJ) | 0.20 | 183.9B | 16.28 | 26.81 | 2.80 | 0.25 | 4.03 | 22.22 | 124.89 |
| Javelin Pharmaceuticals, Inc. (JAV) | -0.41 | 118.3M | NA | -177.69 | NA | NA | 4.59 | NA | -15.50 |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Glaxosmithkline plc (GSK) | -2.01 | 121.2B | 12.70 | 53.12 | 4.40 | 1.11 | 6.85 | 22.99 | 34.63 |
| GeoPharma Inc. (GORX) | 0.00 | 41.2M | NA | -24.84 | NA | 0.67 | 1.17 | -11.30 | -9.57 |
| Evotec AG (EVTC) | 8.96 | 397.3M | NA | -36.18 | NA | 0.07 | 1.12 | -189.25 | -17.81 |
| Eli Lilly & Co. (LLY) | -1.64 | 52.5B | 14.38 | 26.54 | 4.00 | 0.32 | 3.52 | 22.14 | 113.98 |
| CPEX Pharmaceuticals, Inc. (CPEX) | -2.03 | NA | NA | NA | NA | NA | NA | -14.90 | NA |
| Chem Rx Corporation (CHRX.OB) | NA | NA | NA | 3.02 | NA | 2.17 | NA | -0.44 | NA |
| Callisto Pharmaceuticals, Inc. (KAL) | -4.17 | 10.9M | NA | NA | NA | NA | NA | NA | -5.40 |
| Bristol-Myers Squibb Co. (BMY) | -0.87 | 40.8B | 19.13 | 19.46 | 6.00 | 0.61 | 3.86 | 12.76 | 48.05 |
| Avigen Inc. (AVGN) | 11.11 | 89.3M | NA | -43.92 | NA | 0.11 | 1.40 | NA | -17.29 |
| AstraZeneca plc (AZN) | 0.28 | 66.9B | 12.28 | 38.69 | 4.10 | 1.02 | 4.55 | 19.58 | -265.42 |
| APP Pharmaceuticals, Inc. (APPX) | 30.13 | 3.7B | 115.37 | 15.73 | NA | NA | NA | 6.18 | 104.89 |
| AP Pharma Inc. (APPA) | 4.39 | 36.7M | NA | -141.57 | NA | NA | 1.60 | NA | -7.22 |
| Aceto Corp. (ACET) | -6.37 | 165.2M | 17.29 | 7.58 | 2.80 | 0.00 | 1.23 | 3.35 | -15.30 |
| Abbott Laboratories (ABT) | -1.02 | 83.6B | 21.98 | 23.82 | 2.60 | 0.73 | 4.65 | 13.86 | 116.22 |